Yield Theory

Robert Bresnahan · DXCM

Robert Bresnahan's DXCM trades

Every DexCom, Inc. transaction Robert Bresnahan reported to the House Clerk in 2025 and 2026, from the original periodic transaction reports.
Transactions
3
Buys / sells
2 / 1
Disclosed range
$3K – $45K
Last filed
2025-06-09

DXCM transactions reported by Robert Bresnahan

3 of 3 rows
TypeOwner
DexCom, Inc. - Common Stock
DXCM
PurchaseSelf$1,001 - $15,0002025-06-09
#20030482
DexCom, Inc. - Common Stock
DXCM
SaleSelf$1,001 - $15,0002025-04-28
#20030238
DexCom, Inc. - Common Stock
DXCM
PurchaseSelf$1,001 - $15,0002025-03-27
#20029034

A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.

The tracker is free

A STOCK Act row is evidence, not a model portfolio. Membership is the sourced monthly thesis around it.

Get this month’s call for $15

Robert Bresnahan and DXCM — questions

Did Robert Bresnahan buy or sell DXCM?

House Clerk filings for 2025 and 2026 show 2 purchases and 1 sale of DexCom, Inc. (DXCM) reported by Robert Bresnahan, between 2025-02-25 and 2025-05-15. Reported owner: Self.

How much DXCM did Robert Bresnahan trade?

Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $3K – $45K across 3 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.

When was the last DXCM filing by Robert Bresnahan?

The most recent periodic transaction report containing a DXCM row was filed on 2025-06-09. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.

Yield Theory is not affiliated with any elected official or with DexCom, Inc.. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.

Don’t copy the filing. Read the thesis.

Robert Bresnahan DXCM disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included